VANCOUVER - Trish Keating's cancer was a particularly vicious breed of monster.
Her colorectal cancer diagnosis in 2010 was followed by a repeating cycle of surgeries, chemotherapy, radiation and, when she and her doctors thought they had finally slain the beast, relapses.
Keating, who worked as costume designer in the film industry, was told in late 2013 that the cancer had returned once again and this time it was terminal. She might have two or three years to live.
Last fall, Keating, 67, joined a clinical trial in Vancouver that sequenced the genome of her tumour to recommend treatment. She was put on a drug typically used to treat high blood pressure and within five weeks the cancer was barely detectable.
"When you've lived with cancer for five years and you're trying to beat the dragon that's breathing behind you, when finally someone says to you 'We can't see any (cancer)', first of all you're incredulous, kind of in a state of shock," Keating said in an interview.
"It takes a while. It took me and my husband a couple of days for that to set in."
Keating's doctor treated her as part of a B.C. Cancer Agency study into personalized onco-genomics, or POG — an experimental method of examining tumours to identify potential treatment.
While the technique could be years away from widespread clinical use, the researchers hope it could one day allow doctors to customize treatments to each patients' individual tumours and improve their odds of survival.
Dr. Howard Lim said that in Keating's case, the genomic sequencing identified a specific protein as the driving force behind her cancer. His team identified an existing blood-pressure medication known to block pathways to that protein.
"I remember it was right after New Year's and I gave her a call," Lim said, recalling when he received the first test results after five weeks of treatment with the new drug.
"The results came to my desk and I couldn't believe it."
At the two-month mark, Keating's cancer was undetectable and she is considered in remission.
Lim said cancer is currently treated based on its type — colon cancer is typically treated with colon cancer drugs, for example.
But he said that approach fails to recognize patients with the same type of cancer may have tumours that act very differently — and respond to different treatment.
"Therefore, we can't treat all colon cancers the same," Lim said.
"What we're trying to do is tailor and personalize chemotherapy."
That also means the blood-pressure medication used to treat Keating's tumour — which Lim described as unique — won't necessarily help other colorectal cancer patients. Most of the time, the genomics testing recommends some form of traditional chemotherapy, he said.
Lim said researchers still need to determine whether using the POG technique to guide treatment improves survival rates when compared with standard chemotherapy. He said it's also not clear whether it will be equally effective for all types of cancers.
The study has so far included about 170 patients.
The first 100 people were in the late stages of their cancer when they enrolled, Lim said, and about half appeared to have benefited from the study.
The most recent group of 70 patients, who are all considered terminal but entered at earlier stages of their condition, are mostly still receiving treatment and it's too early to evaluate their progress.
"We really cannot guarantee that based on POG-directed therapy you're going to get a response," he said.
"We've also had some people who've had no response. That's the nature of cancers — we don't know anything."
For now, Keating knows she's in uncharted territory.
Her health has improved in ways that no one had predicted, and not even her doctors are sure what her future holds.
"Cancer is a very tenacious organism and it finds ways to beat drugs," she said.
"I'm cautious. But as my dear son says, I don't know anything more than what we have right now, so that's what we have."
Follow @ByJamesKeller on Twitter
Also on HuffPost
Keith Beaty via Getty ImagesThe news anchor lost her husband, Jay, to colorectal cancer in 1998, and she "became determined to share my newfound knowledge about this deadly disease with the public," she wrote online.
She launched the National Colorectal Cancer Research Alliance to help educate people, opened the Jay Monahan Center for Gastrointestinal Health at New York Presbyterian Hospital/Weill Cornell Medical Center and later co-founded Stand Up To Cancer.
Ilya S. Savenok via Getty ImagesWhen she was diagnosed with colon cancer in 2002, the TV personality (and Ozzy's wife) thought, "My work isn't finished here with my family," she told People. That drive to survive got her through surgery and chemo, helping her to remain cancer-free since May 2004. "You can go, 'Why me?' Or you fight the cancer and say, 'You are gone,'" she said.
GettyThe 40th president underwent surgery for colon cancer in July of 1985. Two feet of his colon were removed, according to Fitness magazine. He fully recovered, living until 2004, when he died at the age of 93, after 10 years battling Alzheimer's disease.
GettyThe first Pope to be photographed in a hospital bed, John Paul had surgery to remove colon cancer in 1992. He died in 2005 at age 84.
Charles Eshelman via Getty ImagesThe baseball great, left, underwent surgery and chemotherapy for colon cancer in 1998, and announced in 2000 that the cancer had returned, according to the AP. Strawberry's agent said a CT scan suggested the cancer had spread to the lymph nodes.
Today he is involved in raising autism awareness and engages in various public speaking endeavors.
Slaven Vlasic via Getty ImagesAs a colon cancer survivor, the fashion designer is involved in many efforts to raise awareness for colorectal cancer. He has joined forces with Katie Couric, the NCCRA and the Entertainment Industry Foundation, among others, according to his website.
"Before I was diagnosed with colon cancer I was totally unaware of my own family history relating to the disease. With no family history on record, I was not eligible for prescreening by insurance and would have normally had to wait until the age of 50 for my first colon cancer screening. Had I waited my prognoses would have been much, much different," he has said.
Walter McBride via Getty ImagesThe actress starred in this public service announcement in 2008 alongside Valvo urging people to talk to their doctors to get screened for colorectal cancer.
"My good friend Carmen is living proof that colorectal cancer is treatable. As a first step, we want to encourage people to talk to their doctors about getting screened.," she told People.com.
Raymond Boyd via Getty ImagesThe football coach died at age 57 from colon cancer, after surgery to remove a tumor and a section of his colon. The Vince Lombardi Cancer Foundation, created in his honor, has since raised over $15 million to fund cancer research and care.
Allen Berezovsky via Getty ImagesThe basketball great told CNN, "My grandfather died from colorectal cancer, my uncle died from colorectal cancer and my father almost died from colorectal cancer," adding that he himself has the gene. He became involved in a public awareness campaign, according to CNN, before being diagnosed with leukemia in 2009, at the age of 62. He said his cancer was at "absolute minimum" in 2011.
GettyThe U.S. Supreme Court Justice was diagnosed with early-stage colon cancer in 1999 and never missed a day on the bench during treatment, ABC News reported.
In 2009, it was revealed that she had also undergone surgery to move a small tumor on her pancreas.
Terry O'Neill via Getty ImagesThe actress died in 1993 at the age of 63 from colon cancer. She had undergone surgery in November of 1992, the New York Times reported.
Steve Thorne via Getty ImagesThe singer died in 2008 at age 81 from colon cancer, the AP reported.